156 related articles for article (PubMed ID: 20414018)
1. [Prostate cancer].
Hinotsu S
Gan To Kagaku Ryoho; 2010 Apr; 37(4):620-3. PubMed ID: 20414018
[TBL] [Abstract][Full Text] [Related]
2. [Summary of 'General Rule for Clinical and Pathological Studies on Prostate Cancer (the 3rd Edition)'].
Maeda O; Usami M
Nihon Rinsho; 2005 Feb; 63(2):201-6. PubMed ID: 15714966
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based medicine in prostate cancer: where do we stand in 2006?
Dahm P
Curr Opin Urol; 2006 May; 16(3):162-7. PubMed ID: 16679853
[TBL] [Abstract][Full Text] [Related]
4. EAU guidelines on prostate cancer.
Aus G; Abbou CC; Bolla M; Heidenreich A; Schmid HP; van Poppel H; Wolff J; Zattoni F;
Eur Urol; 2005 Oct; 48(4):546-51. PubMed ID: 16046052
[TBL] [Abstract][Full Text] [Related]
5. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
[TBL] [Abstract][Full Text] [Related]
6. Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.
Droz JP; Balducci L; Bolla M; Emberton M; Fitzpatrick JM; Joniau S; Kattan MW; Monfardini S; Moul JW; Naeim A; van Poppel H; Saad F; Sternberg CN
Crit Rev Oncol Hematol; 2010 Jan; 73(1):68-91. PubMed ID: 19836968
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association.
Cancer Registration Committee of the Japanese Urological Association
Int J Urol; 2005 Jan; 12(1):46-61. PubMed ID: 15661054
[TBL] [Abstract][Full Text] [Related]
8. Prostate specific antigen best practice statement: 2009 update.
Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
[TBL] [Abstract][Full Text] [Related]
9. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
[TBL] [Abstract][Full Text] [Related]
10. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
Dahm P; Yeung LL; Chang SS; Cookson MS
J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
Ito K
Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
[TBL] [Abstract][Full Text] [Related]
12. [Management of prostate cancer--current status and hazards].
Kotake T; Okada K
Hinyokika Kiyo; 1991 Aug; 37(8):781-3. PubMed ID: 1957721
[TBL] [Abstract][Full Text] [Related]
13. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
Epstein JI; Allsbrook WC; Amin MB; Egevad LL
Adv Anat Pathol; 2006 Jan; 13(1):57-9. PubMed ID: 16462155
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of prostate cancer. Practice recommendations from the Finnish Urological Association].
Duodecim; 1999; 115(14):1508-16. PubMed ID: 11912637
[No Abstract] [Full Text] [Related]
15. Re: Axel Heidenreich, Gunnar Aus, Michel Bolla, et al. EAU guidelines on prostate cancer. Eur Urol 2008;53:68-80.
Kirollos M
Eur Urol; 2008 Sep; 54(3):693-5; author reply 695-7. PubMed ID: 18367315
[No Abstract] [Full Text] [Related]
16. Update of the NCCN guidelines for treatment of prostate cancer.
Millikan R; Logothetis C
Oncology (Williston Park); 1997 Nov; 11(11A):180-93. PubMed ID: 9430189
[No Abstract] [Full Text] [Related]
17. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
Fawzy A; Fontenot C; Guthrie R; Baudier MM
Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
[TBL] [Abstract][Full Text] [Related]
18. Advanced prostate cancer treatment guidelines: European perspective.
Tunn UW
BJU Int; 2004 Dec; 94 Suppl 3():6. PubMed ID: 15521884
[No Abstract] [Full Text] [Related]
19. Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract.
Häggman MJ; Adolfsson J; Khoury S; Montie JE; Norlén J
Scand J Urol Nephrol Suppl; 2000; (205):44-9. PubMed ID: 11144903
[TBL] [Abstract][Full Text] [Related]
20. What will the emperor say? Screening for prostate cancer as of 2008.
Concato J
Cancer J; 2009; 15(1):7-12. PubMed ID: 19197166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
